Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Tanabe Seiyaku, Mitsubishi Pharma Corporation to Merge Oct. 1
February 12, 2007
- Tohoku Univ. Researchers Develop New Endoscopic Laser Treatment System
February 12, 2007
- Olympus Applies for Swallowable Imaging Capsule
February 12, 2007
- PREMINENT Opens Door to Combination Drugs
February 12, 2007
- Olympus Launches World's First AFT Videoscopes
February 12, 2007
- GENERIC NEWS IN BRIEF
February 12, 2007
- Original Products Holding Their Own in Competition with Generics
February 12, 2007
- R&D NEWS IN BRIEF
February 12, 2007
- Molecular Imaging Research Symposium 2007
February 12, 2007
- Takeda to Build New Research Center in Fujisawa
February 12, 2007
- REGULATORY NEWS IN BRIEF
February 12, 2007
- Trial Fails to Show Non-Inferiority of Iressa to Docetaxel
February 12, 2007
- 7 Drugs/5 APIs Recommended for Approval
February 12, 2007
- Sysmex Launches New Automated Hematology Analyzer in Europe
February 12, 2007
- Dialogue to Be Held Once or Twice a Year: EAD Director
February 12, 2007
- MEXT to Strengthen Anticancer Efforts in FY2007
February 5, 2007
- Pfizer Japan, Astellas Announce Approval of Celecox
February 5, 2007
- Saiseikai Group to Initiate Study in Preparation for Joint Purchasing
February 5, 2007
- New Industry Vision to Focus on Environment for Drug Discovery: EAD Director
February 5, 2007
- MEDICAL DEVICE NEWS IN BRIEF
February 5, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…